共 50 条
- [31] Question 75: What do you recommend to either prevent the formation of carbonyl sulfide or remove it from the propylene stream? at what level does this become a concern? American Fuel and Petrochemical Manufacturers, AFPM - AFPM Q and A and Technology Forum 2015: FCC Q and A Session, 2015, : 73 - 81
- [36] THE INFLUENCE OF APROTININ ON THE BLOOD LACTATE LEVEL AND ON PARAMETERS OF COAGULATION FOLLOWING TOTAL HIP-REPLACEMENT - A DOUBLE-BLIND CLINICAL-TRIAL LANGENBECKS ARCHIV FUR CHIRURGIE, 1982, 358 : 586 - 586
- [37] EVALUATION OF THE INSIGHT OF HEALTHY-VOLUNTEERS IN THE ETHICAL, PSYCHOLOGICAL AND RELATIONAL ASPECTS FOLLOWING A CLINICAL-TRIAL WITH A NEW BETA-BLOCKER (SL 75.177-10) THERAPIE, 1983, 38 (02): : 155 - 161
- [38] DOES TETANUS IMMUNE GLOBULIN INTERFERE WITH THE IMMUNE-RESPONSE TO SIMULTANEOUS ADMINISTRATION OF TETANUS-DIPHTHERIA VACCINE - A COMPARATIVE CLINICAL-TRIAL IN ADULTS JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 35 (04): : 420 - 425
- [39] WHAT OBJECTIVE SHOULD BE ASSIGNED TO THE VARIOUS SUGGESTED TREATMENTS (NSAIDS, ANALGESICS, FUNDAMENTAL, PREVENTIVE OR CURATIVE TREATMENT) - WHAT TYPES OF PATIENTS SHOULD BE USED IN WHICH TYPE OF CLINICAL-TRIAL REVUE DU RHUMATISME, 1990, 57 (9BIS): : S22 - S24